Skrivanek Z - Search Results

1

Erratum: efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5). Diabetes Care 2014;37:2149-2158.

Nauck M, Weinstock RS, Umpierrez GE, Guerci B, Skrivanek Z, Milicevic Z. Nauck M, et al. Among authors: skrivanek z. Diabetes Care. 2015 Mar;38(3):538. doi: 10.2337/dc15-er03. Diabetes Care. 2015. PMID: 25715416 Free PMC article. No abstract available.

2

Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5).

Nauck M, Weinstock RS, Umpierrez GE, Guerci B, Skrivanek Z, Milicevic Z. Nauck M, et al. Among authors: skrivanek z. Diabetes Care. 2014 Aug;37(8):2149-58. doi: 10.2337/dc13-2761. Epub 2014 Apr 17. Diabetes Care. 2014. PMID: 24742660 Free PMC article. Clinical Trial.

3

Safety and efficacy of once-weekly dulaglutide versus sitagliptin after 2 years in metformin-treated patients with type 2 diabetes (AWARD-5): a randomized, phase III study.

Weinstock RS, Guerci B, Umpierrez G, Nauck MA, Skrivanek Z, Milicevic Z. Weinstock RS, et al. Among authors: skrivanek z. Diabetes Obes Metab. 2015 Sep;17(9):849-58. doi: 10.1111/dom.12479. Epub 2015 May 20. Diabetes Obes Metab. 2015. PMID: 25912221 Free PMC article. Clinical Trial.

4

Dose-finding results in an adaptive, seamless, randomized trial of once-weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD-5).

Skrivanek Z, Gaydos BL, Chien JY, Geiger MJ, Heathman MA, Berry S, Anderson JH, Forst T, Milicevic Z, Berry D. Skrivanek Z, et al. Diabetes Obes Metab. 2014 Aug;16(8):748-56. doi: 10.1111/dom.12305. Epub 2014 May 22. Diabetes Obes Metab. 2014. PMID: 24762094 Free article. Clinical Trial.

5

Low incidence of anti-drug antibodies in patients with type 2 diabetes treated with once-weekly glucagon-like peptide-1 receptor agonist dulaglutide.

Milicevic Z, Anglin G, Harper K, Konrad RJ, Skrivanek Z, Glaesner W, Karanikas CA, Mace K. Milicevic Z, et al. Among authors: skrivanek z. Diabetes Obes Metab. 2016 May;18(5):533-6. doi: 10.1111/dom.12640. Epub 2016 Mar 4. Diabetes Obes Metab. 2016. PMID: 26847401 Clinical Trial.

6

An adaptive, dose-finding, seamless phase 2/3 study of a long-acting glucagon-like peptide-1 analog (dulaglutide): trial design and baseline characteristics.

Geiger MJ, Skrivanek Z, Gaydos B, Chien J, Berry S, Berry D. Geiger MJ, et al. Among authors: skrivanek z. J Diabetes Sci Technol. 2012 Nov 1;6(6):1319-27. doi: 10.1177/193229681200600610. J Diabetes Sci Technol. 2012. PMID: 23294776 Free PMC article. Clinical Trial.

7

Application of adaptive design methodology in development of a long-acting glucagon-like peptide-1 analog (dulaglutide): statistical design and simulations.

Skrivanek Z, Berry S, Berry D, Chien J, Geiger MJ, Anderson JH, Gaydos B. Skrivanek Z, et al. J Diabetes Sci Technol. 2012 Nov 1;6(6):1305-18. doi: 10.1177/193229681200600609. J Diabetes Sci Technol. 2012. PMID: 23294775 Free PMC article. Clinical Trial.

8

Achieving the composite endpoint of glycated haemoglobin <7.0%, no weight gain and no hypoglycaemia in the once-weekly dulaglutide AWARD programme.

Dungan KM, Raz I, Skrivanek Z, Sealls W, Fahrbach JL. Dungan KM, et al. Among authors: skrivanek z. Diabetes Obes Metab. 2016 Jan;18(1):49-55. doi: 10.1111/dom.12575. Epub 2015 Nov 3. Diabetes Obes Metab. 2016. PMID: 26362460 Free PMC article.

9

Operational challenges and solutions with implementation of an adaptive seamless phase 2/3 study.

Spencer K, Colvin K, Braunecker B, Brackman M, Ripley J, Hines P, Skrivanek Z, Gaydos B, Geiger MJ. Spencer K, et al. Among authors: skrivanek z. J Diabetes Sci Technol. 2012 Nov 1;6(6):1296-304. doi: 10.1177/193229681200600608. J Diabetes Sci Technol. 2012. PMID: 23294774 Free PMC article. Clinical Trial.

10

Network meta-analysis accurately predicted the outcome of a subsequent randomised trial comparing once weekly dulaglutide 1.5 mg and once daily liraglutide 1.8 mg.

Fahrbach JL, Fu H, Shurzinske L, Skrivanek Z, Martin S. Fahrbach JL, et al. Among authors: skrivanek z. Int J Clin Pract. 2016 Mar;70(3):218-21. doi: 10.1111/ijcp.12775. Epub 2016 Feb 24. Int J Clin Pract. 2016. PMID: 26916354

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters